PENTAX Medical Announces License Agreement With American Speech-Language-Hearing Association To Digitize Clinical Assessment Tool For Voice Disorders

LOS ANGELES, Nov. 9, 2017 /PRNewswire/ -- PENTAX Medical, a healthcare industry leader in speech, voice and swallowing assessment, announced a new licensing agreement with the American Speech-Language-Hearing Association (ASHA) to incorporate a tool used to help clinicians assess voice problems into a new software module featured in the company’s voice and speech assessment products. The agreement was announced here during the ASHA Annual Convention.

The Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V)* tool was developed by ASHA to provide a standardized protocol and assessment form for speech-language pathologists to describe and document clinical auditory-perceptual assessments of voice quality.

PENTAX Medical has integrated CAPE-V into a new software module called iCAPE-V, which will be loaded into Visi-Pitch and Computerized Speech Lab (CSL), the company’s acoustic products that offer high-quality recordings of patient speech and voice.

The software, which was developed in partnership with ASHA, enables data entry to go from paper to electronic. It gives clinicians the ability to electronically measure CAPE-V scores through a sliding visual analog scale, eliminating the need for hand measurements. It can also automatically fill in patient information fields, allow clinicians to electronically add data, and store and manage patient files in a secure digital database.

“PENTAX Medical is dedicated to working with ASHA and the speech-language pathologist, voice scientist, and logopedist communities to develop products that further the field and help the patient population,” said Jim Cavanaugh, Vice President, Global Product Management, PENTAX Medical. “We are extremely excited to have partnered with ASHA to develop a meaningful advancement to the industry.”

About the American Speech-Language-Hearing (ASHA)
ASHA is the national professional, scientific, and credentialing association for 191,500 members and affiliates who are audiologists; speech-language pathologists; speech, language, and hearing scientists; audiology and speech-language pathology support personnel; and students. Audiologists specialize in preventing and assessing hearing and balance disorders as well as providing audiologic treatment, including hearing aids. Speech-language pathologists identify, assess, and treat speech and language problems, including swallowing disorders. www.asha.org

About PENTAX Medical
PENTAX Medical is a division of Hoya Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopy, informatics, speech, voice, and swallowing assessment products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe. PENTAX Medical employees represent the diverse countries where we do business, allowing us to provide innovative solutions tailored to meet local needs.

*The CAPE-V tool was developed by the American Speech-Language-Hearing Association’s Special Interest Division 3, Voice and Voice Disorders, and is used and reproduced herein under license. © 2017 American Speech-Language-Hearing Association. All rights in and to the CAPE-V tool are reserved and held by the American Speech-Language-Hearing Association. The CAPE-V trademark and the ASHA Logo are the exclusive trademarks of the American Speech-Language-Hearing Association.

View original content with multimedia:http://www.prnewswire.com/news-releases/pentax-medical-announces-license-agreement-with-american-speech-language-hearing-association-to-digitize-clinical-assessment-tool-for-voice-disorders-300552891.html

SOURCE PENTAX Medical